Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach
- PMID: 27344345
- PMCID: PMC5316400
- DOI: 10.1007/s00204-016-1778-8
Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach
Abstract
Hepatotoxicity is one of the major reasons for withdrawal of drugs from the market. Therefore, there is a need to screen new drugs for hepatotoxicity in humans at an earlier stage. The aim of this study was to validate human precision-cut liver slices (PCLS) as an ex vivo model to predict drug-induced cholestasis and identify the possible mechanisms of cholestasis-induced toxicity using gene expression profiles. Five hepatotoxicants, which are known to induce cholestasis (alpha-naphthyl isothiocyanate, chlorpromazine, cyclosporine, ethinyl estradiol and methyl testosterone) were used at concentrations inducing low (<30 %) and medium (30-50 %) toxicity, based on ATP content. Human PCLS were incubated with the drugs in the presence of a non-toxic concentration (60 µM) of a bile acid mixture (portal vein concentration and composition) as model for bile acid-induced cholestasis. Regulated genes include bile acid transporters and cholesterol transporters. Pathway analysis revealed that hepatic cholestasis was among the top ten regulated pathways, and signaling pathways such as farnesoid X receptor- and liver X receptor-mediated responses, which are known to play a role in cholestasis, were significantly affected by all cholestatic compounds. Other significantly affected pathways include unfolded protein response and protein ubiquitination implicating the role of endoplasmic reticulum stress. This study shows that human PCLS incubated in the presence of a physiological bile acid mixture correctly reflect the pathways affected in drug-induced cholestasis in the human liver. In the future, this human PCLS model can be used to identify cholestatic adverse drug reactions of new chemical entities.
Keywords: Cholestasis; Hepatotoxicity; Precision-cut liver slices; Transcriptomics.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices.Chem Res Toxicol. 2016 Mar 21;29(3):342-51. doi: 10.1021/acs.chemrestox.5b00491. Epub 2016 Mar 9. Chem Res Toxicol. 2016. PMID: 26881866
-
Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes.BMC Med Genomics. 2013 Oct 10;6:39. doi: 10.1186/1755-8794-6-39. BMC Med Genomics. 2013. PMID: 24112857 Free PMC article.
-
Rat precision-cut liver slices predict drug-induced cholestatic injury.Arch Toxicol. 2017 Oct;91(10):3403-3413. doi: 10.1007/s00204-017-1960-7. Epub 2017 Apr 8. Arch Toxicol. 2017. PMID: 28391356 Free PMC article.
-
New molecular insights into the mechanisms of cholestasis.J Hepatol. 2009 Sep;51(3):565-80. doi: 10.1016/j.jhep.2009.05.012. Epub 2009 May 28. J Hepatol. 2009. PMID: 19595470 Review.
-
Current insights in the complexities underlying drug-induced cholestasis.Crit Rev Toxicol. 2019 Jul;49(6):520-548. doi: 10.1080/10408444.2019.1635081. Epub 2019 Oct 7. Crit Rev Toxicol. 2019. PMID: 31589080 Review.
Cited by
-
Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures.Arch Toxicol. 2018 Jun;92(6):1939-1952. doi: 10.1007/s00204-018-2214-z. Epub 2018 May 14. Arch Toxicol. 2018. PMID: 29761207 Free PMC article.
-
Toward better drug development: Three-dimensional bioprinting in toxicological research.Int J Bioprint. 2023 Jan 6;9(2):663. doi: 10.18063/ijb.v9i2.663. eCollection 2023. Int J Bioprint. 2023. PMID: 37065668 Free PMC article. Review.
-
The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices.Nutrients. 2021 Nov 24;13(12):4203. doi: 10.3390/nu13124203. Nutrients. 2021. PMID: 34959755 Free PMC article.
-
In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.Arch Toxicol. 2018 May;92(5):1909-1912. doi: 10.1007/s00204-018-2201-4. Epub 2018 Mar 24. Arch Toxicol. 2018. PMID: 29574564 Free PMC article. No abstract available.
-
Precision-cut liver slices: a versatile tool to advance liver research.Hepatol Int. 2019 Jan;13(1):51-57. doi: 10.1007/s12072-018-9913-7. Epub 2018 Dec 4. Hepatol Int. 2019. PMID: 30515676 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources